I have completed the Stanford Physician Well-being director course and am bringing initiatives to the cardiology division and the hospital to improve physician well-being and reduce burnout and attrition for all patient facing health care providers. One example within the division is establishment of town halls and lunch with leaders to improve communication within the division. An example hospital wide is leading commensality meals, bringing together practitioners from different disciplines to come together over a meal and lead discussions related to wellness to promote a feeling of community throughout the hospital.

I am the lead physician for the National Pediatric Collaborative Quality Improvement program (NPCQIC) at Children’s National Medical Center.  The mission of the NPCQIC is to decrease mortality and improve quality of life for infants with single ventricle congenital heart disease and their families. The NPCQIC is a collaborative of parents, clinicians, and researchers in 60 different centers within the United States. I oversee seven physicians who provide care to these patients, meets weekly with the nurse practitioners who are involved in the inpatient and outpatient monitoring of these patients, organizes monthly meetings within CNMC, participates in monthly action period calls for the collaborative and participates in subcommittee meetings in transparency and neurodevelopmental outcomes. I am responsible for Institutional Review Board (IRB) applications and oversight.  I am also the lead physician for the Fontan Outcomes Network (FON) which is a research collaborative improving outcomes over the lifespan for those with single ventricle heart disease. I oversee research staff for consent and data acquisition. 

I am one of three physicians at Children's National Medical Center who provides preventative cardiology care to children with hypercholesterolemia. I have participated in clinical drug trials and multicenter studies as well as given lectures on this subject. I have expertise in non-invasive imaging including echocardiography and vascular ultrasound. Because of these proficiencies she was asked to participate in a landmark natural history study of Hutchinson-Guilford-Progeria Syndrome. Dr. Clauss was the sole cardiologist on this study responsible for patient oversight, interpretation of transthoracic echocardiograms, stress echocardiograms, carotid imaging and treatment of dyslipidemias in this population. I oversee the noninvasive vascular lab at Children’s National Medication Center and supervise the acquisition and quality control for carotid intima media thickness and pulse wave velocity for the PHN funded study Atherogenic combined dyslipidemia of obesity (Do It!). This study characterized the nature and clinical course of dyslipidemia evaluate statin side effects in youth.

I have been identified by the Familial Hyperlipidemia (FH) society as one of the leaders in preventative cardiology. Because of her expertise in this field, she has been selected in participate in an invitation only meeting held yearly by the FH society that brings leaders and innovators of this field together to push science forward to improve care and outcomes for these patients. I have been selected to be a physician educator and patient advocate for the FH society.

Finally, I have served as primary clinical and career mentors for many fellows and new faculty. I have developed outpatient lecture series on common outpatient pediatric cardiac complaints. I have aggregate scores of 4.67/5 for teaching effectiveness.